Sovaldi and Harvoni land on 13 hospitals and start to be supplied
Prescriptions of ‘Sovaldi(sofosbuvir),’ a large hepatitis C treatment, and ‘Harvoni(sofosbuvir and ledipasvir),’ a complex, have started in the domestic market.
Gilead Sciences Korea announced supply of the two oral treatments of chronic hepatitis C without the health insurance benefits from the...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
